New bioprosthetic valve for TAVR fails to demonstrate non-inferiority

NEW YORK – October 15, 2020 – In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve. Findings were reported today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT…

Details

Results from the MITHRAS trial reported at TCT Connect and published in Circulation

NEW YORK – October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance. Findings were reported today at TCT…

Details

ISSCR’s stem cell based clinical trials guide recognized by Tech Spotlight

Skokie, IL–The ISSCR’s Stem Cell-Based Clinical Trials: Practical Advice for Physicians and Ethics/Institutional Review Committees was honored today by Tech Spotlight at Harvard Kennedy School’s Belfer Center. Tech Spotlight recognizes the technologists, activists, and policymakers who are thoughtfully creating and using technology in ways to protect the public good and help shape a better future.…

Details

Among Us: You’re the Impostor

When an indie game company created Among Us in 2018, it was greeted with little fanfare. The multiplayer game remained under the radar as many games do — until the summer of the pandemic. Eager to keep viewers entertained during quarantine, Chance Morris, known online as Sodapoppin, began streaming the game, created by InnerSloth, to…

Details